UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported):
                                February 5, 2004

                        OMEGA HEALTHCARE INVESTORS, INC.
             (Exact name of registrant as specified in its charter)

      MARYLAND                         1-11316                   38-3041398
(State of Incorporation)        (Commission File Number)      (I.R.S. Employer
                                                             Identification No.)

                          9690 DEERECO ROAD, SUITE 100
                            TIMONIUM, MARYLAND 21093
                                 (410) 427-1700
                  (Address and telephone number of Registrant)




ITEM 5.  OTHER EVENTS.

     Omega Healthcare Investors, Inc. (the "Company") is revising its historical
financial  statements  in  connection  with  the  application  of  Statement  of
Financial  Accounting Standards ("SFAS") No. 144, "Accounting for the Impairment
or Disposal of Long-Lived  Assets,"  regarding assets disposed during the period
from January 1, 2003 to September 30, 2003 and SFAS No. 145, "Rescission of FASB
Statements  No. 4, 44 and 64,  Amendment of FASB Statement No. 13, and Technical
Corrections."  During the first nine months of 2003,  the Company  sold  certain
properties and in compliance  with SFAS 144 has reported  revenue,  expenses and
gain or (loss) on sale from these properties as income (loss) from  discontinued
operations  for each period  presented in its quarterly  reports filed since the
date of the sales (including the comparable period of the prior year). Under SEC
requirements the same  reclassification  as discontinued  operations required by
SFAS 144  following the sale of  properties  is required for  previously  issued
annual  financial  statements for each of the three years shown in the Company's
last  annual  report on Form  10-K,  if those  financials  are  incorporated  by
reference in  subsequent  filings with the  Securities  and Exchange  Commission
("SEC") made under the Securities Act of 1933, as amended.

     The  reclassifications  resulting from asset dispositions have no effect on
the  Company's  reported  net income  available  to common  shareholders  or the
Company's balance sheet.

     This report on Form 8-K updates Items 6, 7, 8 and 15 of the Company's  Form
10-K to reflect those  properties sold during the period from January 1, 2003 to
September 30, 2003 as discontinued operations.  All other items of the Form 10-K
remain  unchanged.  No attempt has been made to update  matters in the Form 10-K
except to the extent expressly provided above.

     The  information  presented  in Exhibit 99.1 does not reflect the impact of
asset dispositions during the fourth quarter of 2003 because the Company has not
yet filed  financial  statements  for the fourth  quarter of 2003. The Company's
annual report on Form 10-K for the year ended December 31, 2003 will  reclassify
reported revenue,  expenses and gain or (loss) on sale of properties sold in the
fourth  quarter of 2003 as income (loss) from  discontinued  operations  for all
prior periods presented. Accordingly, the results for 2002 and 2001 presented in
our Form 10-K for the year ended  December  31, 2003 will differ from the result
presented  in Exhibit 99.1  because of the impact of asset  dispositions  in the
fourth quarter of 2003.

ITEM 7.  EXHIBITS.

23.1 Consent of Independent Auditors

     99.1 Revised  financial  information for the years ended December 31, 2002,
2001  and  2000  for  the  application  of SFAS  No.  144,  "Accounting  for the
Impairment or Disposal of Long-Lived  Assets,"  regarding assets disposed during
the  period  from  January  1,  2003 to  September  30,  2003 and SFAS No.  145,
"Rescission of FASB Statements No. 4, 44 and 64, Amendment of FASB Statement No.
13, and Technical Corrections."

Index to Exhibit 99.1                                           Page Number

     Selected Financial Data

     Management's  Discussion and Analysis of Results of Operation
        and Financial Condition

     Consolidated Financial Statements



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                   OMEGA HEALTHCARE INVESTORS, INC.

                                   /S/  C. TAYLOR PICKETT
                                   ---------------------------------
                                   Name:  C. Taylor Pickett
                                   Title: Chief Executive Officer

Dated:  February 5, 2004